PAR has an unmet need with a TAM much much bigger than this in regards to possible revenue. As for RAC u clearly don’t know what they have which is fine but they have clinical results to show, this has nothing. If the market doesn’t care about great clinical results atm then it won’t care much for ILA and dosing people.
ILA Price at posting:
7.3¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)